Emotional and Behavioral Disorders in Children and Adolescents

Table of Contents

• INTRODUCTION
  • STUDY OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • CONTRIBUTIONS OF THE STUDY
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ABOUT THE AUTHOR
  • RELATED BCC REPORTS
  • BCC ONLINE SERVICES
  • DISCLAIMER
• SUMMARY
  • Summary Table: WORLDWIDE SALES OF DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Summary Figure: WORLDWIDE SALES OF DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• OVERVIEW
  • DEFINITIONS OF EMOTIONAL AND/OR BEHAVIOR DISORDERS
    • DEFINITIONS OF EMOTIONAL AND/OR・CONTINUED)
  • TERMINOLOGY
  • CLASSIFICATION OF EMOTIONAL AND BEHAVIORAL DISORDERS
  • Table 1 DSM CLASSIFICATIONS* OF EMOTIONAL AND BEHAVIORAL DISORDERS
  • Table 2 CLASSIFICATION OF EMOTIONAL AND BEHAVIORAL DISORDERS (AS DONE FOR THIS REPORT)
• CAUSES OF EMOTIONAL AND BEHAVIOR DISORDERS
  • BIOLOGICAL FACTORS
    • PSYCHOPHYSIOLOGICAL AND GENETIC INFLUENCES
    • NEUROLOGICAL DYSREGULATION
  • ENVIRONMENTAL FACTORS
    • SCHOOL-RELATED FACTORS
    • PARENT PSYCHOLOGICAL FACTORS
    • FAMILIAL CONTRIBUTIONS
      • Divorce, Marital Distress and Violence
      • Family Adversity and Insularity
      • Parent-child Interactions
      • Other Family Characteristics
  • CHARACTERISTICS OF STUDENTS WITH BEHAVIOR DISORDERS
    • INTELLIGENCE AND ACHIEVEMENT
      • Social Skills and Interpersonal Relationships
      • Antisocial Behavior
      • Withdrawn Behavior
    • MANIFESTATIONS OF BEHAVIOR DISORDERS
• TYPES OF DISORDERS
  • ANXIETY DISORDERS
    • TYPES OF ANXIETY DISORDERS
    • CAUSES
    • SYMPTOMS AND TREATMENT
      • Psychological Treatments
      • Psychopharmacological Treatments
      • Environmental Treatments
  • SEVERE DEPRESSION
    • CAUSES
    • SYMPTOMS AND TREATMENT
      • Symptoms and Treatment (Continued)
  • BIPOLAR DISORDER
    • SYMPTOMS AND TREATMENT
      • Symptoms and Treatment (Continued)
  • ATTENTION DEFICIT HYPERACTIVITY DISORDER
    • SYMPTOMS AND TREATMENT
  • AUTISM
    • SYMPTOMS AND TREATMENT
  • SCHIZOPHRENIA
    • SYMPTOMS AND TREATMENT
  • LEARNING DISORDERS
    • SYMPTOMS AND TREATMENT
    • CAUSES
  • CONDUCT DISORDER
    • SYMPTOMS AND TREATMENT
  • EATING DISORDERS
    • SYMPTOMS AND TREATMENTS
• DRUG CLASSIFICATION
  • CLASSIFICATION BASED ON MECHANISM OF ACTION
    • BENZODIAZEPINES
  • Table 3 BENZODIAZEPINES
    • SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS)
  • Table 4 SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS)
    • TRICYCLIC ANTIDEPRESSANTS
  • Table 5 TRICYCLIC ANTIDEPRESSANTS
    • ANTIHISTAMINES
  • Table 6 ANTIHISTAMINES
    • MAJOR TRANQUILIZERS OR NEUROLEPTICS
  • Table 7 MAJOR TRANQUILIZERS, NEUROLEPTICS OR ANTIPSYCHOTICS
    • MOOD STABILIZERS
  • Table 8 MOOD STABILIZERS
    • CNS STIMULANTS
  • Table 9 CNS STMULANTS
    • NONSTIMULANTS
  • Table 10 NONSTMULANTS
    • ATYPICAL ANTIPSYCHOTICS
  • Table 11 ATYPICAL ANTIPSYCHOTICS
    • CLASSIFICATION BASED ON THERAPEUTIC CATEGORY
      • ANTIANXIETY DRUGS
  • Table 12 DRUGS USED FOR ANTIANXIETY DISORDERS
  • Table 12 (CONTINUED)
    • Clorazepate
    • Chlordiazepoxide
    • Chlorpromazine
    • Clonezepam
    • Diazepam
    • Doxipine
    • Fluoxetine Hydrochloride
    • Fluphenazine
    • Fluvoxamine Maleate
    • Haloperidol
    • Hydroxyzine
    • Nortriptyline
    • Oxazepam
    • Sertraline Hydrochloride
    • Thioridazine
    • Thioxanthene
    • Trifluperazine
    • SEVERE DEPRESSION DRUGS
  • Table 13 DRUGS USED FOR SEVERE DEPRESSION
    • Amitryptyline
    • Fluoxetine Hydrochloride
    • Impramine
    • Sertraline Hydrochloride
    • BIPOLAR DISORDER DRUGS
  • Table 14 DRUGS USED FOR BIPOLAR DISORDER
    • Lithium
    • Divalproex
    • Carbamazepine
    • ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUGS
  • Table 15 DRUGS USED FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER
    • Amphetamines
    • Dextroamphetamine
    • Methylphenidate
    • Pemoline
    • Atomoxetine Hydrochloride
    • AUTISTIC DISORDER DRUGS
  • Table 16 DRUGS USED FOR AUTISTIC DISORDER TREATMENT
    • Risperidone
    • SCHIZOPHRENIA DRUGS
  • Table 17 DRUGS USED FOR SCHIZOPHRENIA
• SAFETY, EFFICACY AND REGULATION
  • SAFETY AND EFFICACY
    • SAFETY AND EFFICACY (CONTINUED)
  • Table 18 LABELLED USE AND APPROVED AGE FOR AGENTS TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS
    • REGULATORY ASPECTS
      • REGULATORY ASPECTS (CONTINUED)
      • REGULATORY ASPECTS (CONTINUED)
  • Table 19 DRUGS RECEIVING A BOXED WARNING, OTHER PRODUCT LABELING CHANGES, AND A MEDICATION GUIDE PERTAINING TO PEDIATRIC SUICIDAL TENDENCIES
    • DRUG APPROVALS
  • Table 20 DEVICES AND IMPLANTS APPROVED BY THE FDA 2000-APRIL 2005
• INDUSTRY STRUCTURE
  • BEHAVIOR AND EMOTIONAL DISORDER DRUG INDUSTRY MARKET BY COMPANY
    • ANTIANXIETY
  • Table 21 MARKET SHARES OF MANUFACTURERS OF ANTIANXIETY AGENTS TO TREAT BEHAVIOR AND EMOTIONAL DISORDERS, 2004 (%)
  • Figure 1 MARKET SHARES OF MANUFACTURERS OF ANTIANXIETY AGENTS TO TREAT BEHAVIOR AND EMOTIONAL DISORDERS, 2004 (%)
    • Antidepressants
  • Table 22 MARKET SHARES OF MANUFACTURERS OF ANTIDEPRESSANT AGENTS TO TREAT BEHAVIOR AND EMOTIONAL DISORDERS, 2004 (%)
  • Figure 2 MARKET SHARES OF MANUFACTURERS OF ANTIDEPRESSANT AGENTS TO TREAT BEHAVIOR AND EMOTIONAL DISORDERS, 2004 (%)
    • Bipolar Disorders
  • Table 23 MARKET SHARES OF MANUFACTURERS PRODUCING DRUGS FOR BIPOLAR DISORDER TREATMENT, 2004 (%)
  • Figure 3 MARKET SHARES OF MANUFACTURERS PRODUCING BIPOLAR DISORDER DRUGS, 2004 (%)
    • ADHD Disorders
  • Table 24 MARKET SHARES OF MANUFACTURERS PRODUCING ADHD DRUGS FOR TREATING BEHAVIOR AND EMOTIONAL DISORDERS, 2004 (%)
  • Figure 4 MARKET SHARES OF MANUFACTURERS OF ADHD DRUGS FOR TREATING BEHAVIOR AND EMOTIONAL DISORDERS, 2004 (%)
    • Autistic Disorders
  • Table 25 MARKET SHARES OF MANUFACTURERS OF AUTISTIC DISORDER DRUGS, 2004 (%)
  • Figure 5 MARKET SHARES OF MANUFACTURERS OF AUTISTIC DISORDER DRUGS, 2004 (%)
    • Schizophrenia
  • Table 26 MARKET SHARES OF MANUFACTURERS OF DRUGS FOR TREATING SCHIZOPHRENIA, 2004 (%)
  • Figure 6 MARKET SHARES OF MANUFACTURERS OF DRUGS FOR TREATING SCHIZOPHRENIA, 2004 (%)
    • Learning Disorders
  • Table 27 MARKET SHARES OF MANUFACTURERS OF DRUGS FOR TREATING LEARNING DISORDERS, 2004 (%)
  • Figure 7 MARKET SHARES OF MANUFACTURERS OF DRUGS FOR TREATING LEARNING DISORDERS, 2004 (%)
    • Eating Disorders
  • Table 28 MARKET SHARES OF MANUFACTURERS OF DRUGS FOR TREATING EATING DISORDERS, 2004 (%)
  • Figure 8 MARKET SHARES OF MANUFACTURERS OF DRUGS TO TREAT EATING DISORDERS, 2004 (%)
    • Conduct Disorders
  • Table 29 MARKET SHARES OF MANUFACTURERS OF CONDUCT DISORDER DRUGS, 2004 (%)
  • Figure 9 MARKET SHARES OF MANUFACTURERS OF CONDUCT DISORDER DRUGS, 2004 (%)
• MARKET BY DRUG TYPES
  • TOTAL MARKET SIZE
  • Table 30 WORLDWIDE SALES OF DRUGS BY TYPE TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Table 31 PROPORTION OF TYPES OF DRUGS BEING USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2004
  • Figure 10 PROPORTION OF TYPES OF DRUGS BEING USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2004 (%)
    • SALES BY TYPE OF THERAPEUTIC CATEGORY
      • BENZODIAZEPINES
  • Table 32 WORLDWIDE SALES OF BENZODIAZEPINES USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 11 WORLDWIDE SALES OF BENZODIAZEPINES USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS)
  • Table 33 WORLDWIDE SALES OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 12 WORLDWIDE SALES OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • TRICYCLIC ANTIDEPRESSANTS
  • Table 34 WORLDWIDE SALES OF TRICYCLIC ANTIDEPRESSANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 13 WORLDWIDE SALES OF TRICYCLIC ANTIDEPRESSANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • ANTIHISTAMINES
  • Table 35 WORLDWIDE SALES OF ANTIHISTAMINES USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 14 WORLDWIDE SALES OF ANTIHISTAMINES USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • MAJOR TRANQUILIZERS, NEUROLEPTICS OR ANTIPSYCHOTICS
  • Table 36 WORLDWIDE SALES OF MAJOR TRANQILIZERS, NEUROLEPTICS OR ANTIPSYCHOTICS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 15 WORLDWIDE SALES OF MAJOR TRANQILIZERS, NEUROLEPTICS OR ANTIPSYCHOTICS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • MOOD STABILIZERS
  • Table 37 WORLDWIDE SALES OF MOOD STABILIZERS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 16 WORLDWIDE SALES OF MOOD STABILIZERS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • CNS STIMULANTS
  • Table 38 WORLDWIDE SALES OF CNS STIMULANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 17 WORLDWIDE SALES OF CNS STIMULANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • NONSTIMULANTS
  • Table 39 WORLDWIDE SALES OF NONSTIMULANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 18 WORLDWIDE SALES OF NONSTIMULANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • ATYPICAL ANTIPSYCHOTICS
  • Table 40 WORLDWIDE SALES OF ATYPICAL ANTIPSYCHOTICS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 19 WORLDWIDE SALES OF ATYPICAL ANTIPSYCHOTICS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• MARKET BY DISORDERS
  • TOTAL MARKET SIZE
  • Table 41 WORLDWIDE SALES OF DRUGS BY TYPE OF DISORDER TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Table 42 PERCENTAGE SHARE OF GLOBAL MARKET FOR DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS BY DISORDER TYPE, 2004 (%)
  • Figure 20 SHARES OF GLOBAL MARKET FOR DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS BY DISORDER TYPE, 2004 (%)
    • SALES BY TYPE OF DRUGS
      • ANTIANXIETY AGENTS
  • Table 43 WORLDWIDE SALES OF ANTIANXIETY DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 21 WORLDWIDE SALES OF ANTIANXIETY DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • DRUGS USED TO TREAT DEPRESSION
  • Table 44 WORLDWIDE SALES OF ANTIDEPRESSANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 22 WORLDWIDE SALES OF ANTIDEPRESSANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • DRUGS USED TO TREAT BIPOLAR DISORDER
  • Table 45 WORLDWIDE SALES OF DRUGS TO TREAT BIPOLAR EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 23 WORLDWIDE SALES OF DRUGS TO TREAT BIPOLAR EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • ADHD DRUGS
  • Table 46 WORLDWIDE SALES OF ADHD DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 24 WORLDWIDE SALES OF ADHD DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • AUTISTIC DISORDER DRUGS
  • Table 47 WORLDWIDE SALES OF AUTISTIC DISORDER DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 25 WORLDWIDE SALES OF AUTISTIC DISORDER DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • SCHIZOPHRENIA DRUGS
  • Table 48 WORLDWIDE SALES OF SCHIZOPHRENIA DRUGS TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 26 WORLDWIDE SALES OF SCHIZOPHRENIA DRUGS TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • DRUGS FOR LEARNING DISORDERS
  • Table 49 WORLDWIDE SALES OF DRUGS USED TO TREAT LEARNING DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 27 WORLDWIDE SALES OF DRUGS USED TO TREAT LEARNING DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • DRUGS FOR EATING DISORDERS
  • Table 50 WORLDWIDE SALES OF DRUGS USED TO TREAT EATING DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 28 WORLDWIDE SALES OF DRUGS USED TO TREAT EATING DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • CONDUCT DISORDER DRUGS
  • Table 51 WORLDWIDE SALES OF DRUGS TO TREAT CONDUCT DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 29 WORLDWIDE SALES OF DRUGS TO TREAT CONDUCT DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• DEMOGRAPHICS
  • OVERVIEW
    • ANTIANXIETY AGENTS
  • Table 52 DEMOGRAPHICS OF ANTIANXIETY DRUG USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
  • Figure 30 DEMOGRAPHICS OF ANTIANXIETY DRUG USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
    • ANTIDEPRESSANTS
  • Table 53 DEMOGRAPHICS FOR ANTIDEPRESSANT DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
  • Figure 31 DEMOGRAPHICS FOR ANTIDEPRESSANT DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
    • BIPOLAR DISORDER DRUGS
  • Table 54 DEMOGRAPHICS FOR BIPOLAR DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
  • Figure 32 DEMOGRAPHICS FOR BIPOLAR DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
    • ADHD DRUGS
  • Table 55 DEMOGRAPHICS FOR ADHD DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
  • Figure 33 DEMOGRAPHICS FOR ADHD DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
    • AUTISTIC DISORDER DRUGS
  • Table 56 DEMOGRAPHICS FOR AUTISTIC DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
  • Figure 34 DEMOGRAPHICS FOR AUTISTIC DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
    • SCHIZOPHRENIA DRUGS
  • Table 57 DEMOGRAPHICS FOR DRUGS USED TO TREAT SCHIZOPHRENIA IN CHILDREN AND ADOLESCENTS, 2004 (%)
  • Figure 35 DEMOGRAPHICS FOR DRUGS USED TO TREAT SCHIZOPHRENIA IN CHILDREN AND ADOLESCENTS, 2004 (%)
    • LEARNING DISORDER DRUGS
  • Table 58 DEMOGRAPHICS FOR LEARNING DISORDER DRUGS IN CHILDREN AND ADOLESCENTS, 2004 (%)
  • Figure 36 DEMOGRAPHICS FOR LEARNING DISORDER DRUGS IN CHILDREN AND ADOLESCENTS, 2004 (%)
    • EATING DISORDER DRUGS
  • Table 59 DEMOGRAPHICS FOR EATING DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
  • Figure 37 DEMOGRAPHICS FOR EATING DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
    • CONDUCT DISORDER DRUGS
  • Table 60 DEMOGRAPHICS FOR CONDUCT DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
  • Figure 38 DEMOGRAPHICS FOR CONDUCT DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• NEW DEVELOPMENTS
  • NEW DEVELOPMENTS
    • AstraZeneca
  • Table 61 NEW DRUGS FROM ASTRAZENECA
    • Bristol-Myers Squibb
  • Table 62 NEW DRUGS FROM BRISTOL-MYERS SQUIBB
    • Celgene
  • Table 63 NEW DRUGS FROM CELGENE
    • GlaxoSmithKline
  • Table 64 NEW DRUGS FROM GLAXOSMITHKLINE
  • Table 64 (CONTINUED)
    • Johnson & Johnson
  • Table 65 NEW DRUGS FROM JOHNSON & JOHNSON
    • Merck
  • Table 66 NEW DRUGS FROM MERCK
    • Novartis
  • Table 67 NEW DRUGS FROM NOVARTIS
    • Pfizer
  • Table 68 NEW DRUGS FROM PFIZER
    • Roche
  • Table 69 NEW DRUGS FROM ROCHE
    • Sanolfi-Aventis
  • Table 70 NEW DRUGS FROM SANOFI-AVENTIS
    • Shire
  • Table 71 NEW DRUGS FROM SHIRE
    • Solvay
  • Table 72 NEW DRUGS FROM SOLVAY
    • Wyeth
  • Table 73 NEW DRUGS FROM WYETH
• PATENTS
  • PATENTS BY YEAR
  • Table 74 ANNUAL NUMBER OF PATENTS RELATING TO TREATMENTS FOR EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2001-2005
  • Figure 39 TOTAL PATENTS FOR EMOTIONAL AND BEHAVIORAL DISORDER TREATMENTS IN CHILDREN AND ADOLESCENTS, 2001-2005
  • Figure 40 ANNUAL SHARE OF PATENTS FOR EMOTIONAL AND BEHAVIORAL DISORDER TREATMENTS IN CHILDREN AND ADOLESCENTS, 2001-2005 (%)
    • PATENTS BY CATEGORY
  • Table 75 TOTAL NUMBER OF PATENTS RELATING TO TREATMENTS FOR EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS BY CATEGORY, 2001-2005
  • Figure 41 TOTAL NUMBER OF PATENTS RELATING TO TREATMENTS FOR EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS BY CATEGORY, 2001-2005
  • Figure 42 SHARE OF TOTAL NUMBER OF PATENTS RELATING TO TREATMENTS FOR EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS BY CATEGORY, 2001-2005 (%)
    • SIGNIFICANT PATENTS OF 2005
  • Table 76 SIGNIFICANT PATENTS FOR DRUGS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS, 2005
    • PATENTS BY COMPANY
  • Table 77 U.S. PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS BY COMPANY, 2001-2005
  • Table 77 (CONTINUED)
    • PATENTS BY COUNTRY
  • Table 78 U.S. PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS BY COUNTRY, 2001-2005 (NUMBER OF PATENTS)
  • Table 78 (CONTINUED)
  • Figure 43 U.S. PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS BY COUNTRY, 2001-2005 (NUMBER OF PATENTS)
  • Table 79 TRENDS OF PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS ISSUED BY COUNTRY, 2005-2001
  • Figure 44 TRENDS OF PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS ISSUED BY COUNTRY, 2001-2005
  • Figure 45 SHARE OF PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS ISSUED BY COUNTRY, 2001-2005 (%)
    • PATENTS BY ASSIGNEE
  • Table 80 NUMBER AND SHARE OF U.S. PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS BY ASSIGNEE, 2001-2005
  • Figure 46 NUMBER OF U.S. PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS BY ASSIGNEE, 2001-2005 (NUMBER OF PATENTS)
  • Figure 47 SHARES OF U.S. PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS BY ASSIGNEE, 2001-2005 (%)
• INTERNATIONAL ASPECTS
  • TOTAL MARKET SIZE
  • Table 81 REGIONAL SALES OF TREATMENTS FOR BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
    • REGIONAL SALES BY TYPE OF DISORDER
      • ANTIANXIETY AGENTS
  • Table 82 REGIONAL SALES OF ANTIANXIETY AGENTS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 48 REGIONAL SALES OF ANTIANXIETY AGENTS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • ANTIDEPRESSANTS
  • Table 83 REGIONAL SALES OF ANTIDEPRESSANTS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 49 REGIONAL SALES OF ANTIDEPRESSANTS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • BIPOLAR DISORDER DRUGS
  • Table 84 REGIONAL SALES OF BIPOLAR DISORDER DRUGS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 50 REGIONAL SALES OF BIPOLAR DISORDER DRUGS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • ADHD DRUGS
  • Table 85 REGIONAL SALES OF ADHD DRUGS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 51 REGIONAL SALES OF ADHD DRUGS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • AUTISTIC DISORDER DRUGS
  • Table 86 REGIONAL SALES OF AUTISTIC DISORDER DRUGS TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 52 REGIONAL SALES OF ADHD DRUGS TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • SCHIZOPHRENIA DRUGS
  • Table 87 REGIONAL SALES OF DRUGS TO TREAT SCHIZOPHRENIC DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 53 REGIONAL SALES OF DRUGS TO TREAT SCHIZOPHRENIC DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • Learning Disorder Drugs
  • Table 88 REGIONAL SALES OF LEARNING DISORDER DRUGS TO TREAT CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 54 REGIONAL SALES OF LEARNING DISORDER DRUGS TO TREAT CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • Conduct Disorder Drugs
  • Table 89 REGIONAL SALES OF CONDUCT DISORDER DRUGS USED TO TREAT CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 55 REGIONAL SALES OF CONDUCT DISORDER DRUGS USED TO TREAT CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • Eating Disorder Drugs
  • Table 90 REGIONAL SALES OF EATING DISORDER DRUGS TO TREAT CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
  • Figure 56 REGIONAL SALES OF EATING DISORDER DRUGS TO TREAT CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
    • PREVELANCE OF EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS IN SELECTED COUNTRIES
      • UNITED STATES
      • UNITED KINGDOM
      • INDIA
      • CHINA
        • China (Continued)
• COMPANY PROFILES
  • ABBOTT LABORATORIES
  • ALLIANT PHARMACEUTICALS
  • BRISTOL-MYERS SQUIBB
  • CELEGENE
  • CELLTECH PHARMACEUTICALS
  • ELI LILLY
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • JOHNSON & JOHNSON (CONTINUED)
  • MALLINCKRODT MEDICAL
  • NOVARTIS PHARMACEUTICAL CORP.
  • OVATION PHARMACEUTICALS
  • PFIZER, INC.
  • ROCHE
  • SHIRE
  • SOLVAY
  • VALEANT PHARMACEUTICALS
• LIST OF TABLES
• Summary Table:
• Table 1 DSM CLASSIFICATIONS* OF EMOTIONAL AND BEHAVIORAL DISORDERS
• Table 2 CLASSIFICATION OF EMOTIONAL AND BEHAVIORAL DISORDERS (AS DONE FOR THIS REPORT)
• Table 3 BENZODIAZEPINES
• Table 4 SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS)
• Table 5 TRICYCLIC ANTIDEPRESSANTS
• Table 6 ANTIHISTAMINES
• Table 7 MAJOR TRANQUILIZERS, NEUROLEPTICS OR ANTIPSYCHOTICS
• Table 8 MOOD STABILIZERS
• Table 9 CNS STMULANTS
• Table 10 NONSTMULANTS
• Table 11 ATYPICAL ANTIPSYCHOTICS
• Table 12 DRUGS USED FOR ANTIANXIETY DISORDERS
• Table 13 DRUGS USED FOR SEVERE DEPRESSION
• Table 14 DRUGS USED FOR BIPOLAR DISORDER
• Table 15 DRUGS USED FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER
• Table 16 DRUGS USED FOR AUTISTIC DISORDER TREATMENT
• Table 17 DRUGS USED FOR SCHIZOPHRENIA
• Table 18 LABELLED USE AND APPROVED AGE FOR AGENTS TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS
• Table 19 DRUGS RECEIVING A BOXED WARNING, OTHER PRODUCT LABELING CHANGES, AND A MEDICATION GUIDE PERTAINING TO PEDIATRIC SUICIDAL TENDENCIES
• Table 20 DEVICES AND IMPLANTS APPROVED BY THE FDA 2000-APRIL 2005
• Table 21 MARKET SHARES OF MANUFACTURERS OF ANTIANXIETY AGENTS TO TREAT BEHAVIOR AND EMOTIONAL DISORDERS, 2004 (%)
• Table 22 MARKET SHARES OF MANUFACTURERS OF ANTIDEPRESSANT AGENTS TO TREAT BEHAVIOR AND EMOTIONAL DISORDERS, 2004 (%)
• Table 23 MARKET SHARES OF MANUFACTURERS PRODUCING DRUGS FOR BIPOLAR DISORDER TREATMENT, 2004 (%)
• Table 24 MARKET SHARES OF MANUFACTURERS PRODUCING ADHD DRUGS FOR TREATING BEHAVIOR AND EMOTIONAL DISORDERS, 2004 (%)
• Table 25 MARKET SHARES OF MANUFACTURERS OF AUTISTIC DISORDER DRUGS, 2004 (%)
• Table 26 MARKET SHARES OF MANUFACTURERS OF DRUGS FOR TREATING SCHIZOPHRENIA, 2004 (%)
• Table 27 MARKET SHARES OF MANUFACTURERS OF DRUGS FOR TREATING LEARNING DISORDERS, 2004 (%)
• Table 28 MARKET SHARES OF MANUFACTURERS OF DRUGS FOR TREATING EATING DISORDERS, 2004 (%)
• Table 29 MARKET SHARES OF MANUFACTURERS OF CONDUCT DISORDER DRUGS, 2004 (%)
• Table 30 WORLDWIDE SALES OF DRUGS BY TYPE TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 31 PROPORTION OF TYPES OF DRUGS BEING USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2004
• Table 32 WORLDWIDE SALES OF BENZODIAZEPINES USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 33 WORLDWIDE SALES OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 34 WORLDWIDE SALES OF TRICYCLIC ANTIDEPRESSANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 35 WORLDWIDE SALES OF ANTIHISTAMINES USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 36 WORLDWIDE SALES OF MAJOR TRANQILIZERS, NEUROLEPTICS OR ANTIPSYCHOTICS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 37 WORLDWIDE SALES OF MOOD STABILIZERS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 38 WORLDWIDE SALES OF CNS STIMULANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 39 WORLDWIDE SALES OF NONSTIMULANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 40 WORLDWIDE SALES OF ATYPICAL ANTIPSYCHOTICS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 41 WORLDWIDE SALES OF DRUGS BY TYPE OF DISORDER TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 42 PERCENTAGE SHARE OF GLOBAL MARKET FOR DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS BY DISORDER TYPE, 2004 (%)
• Table 43 WORLDWIDE SALES OF ANTIANXIETY DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 44 WORLDWIDE SALES OF ANTIDEPRESSANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 45 WORLDWIDE SALES OF DRUGS TO TREAT BIPOLAR EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 46 WORLDWIDE SALES OF ADHD DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 47 WORLDWIDE SALES OF AUTISTIC DISORDER DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 48 WORLDWIDE SALES OF SCHIZOPHRENIA DRUGS TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 49 WORLDWIDE SALES OF DRUGS USED TO TREAT LEARNING DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 50 WORLDWIDE SALES OF DRUGS USED TO TREAT EATING DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010
• ($ MILLIONS)
• Table 51 WORLDWIDE SALES OF DRUGS TO TREAT CONDUCT DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010
• ($ MILLIONS)
• Table 52 DEMOGRAPHICS OF ANTIANXIETY DRUG USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Table 53 DEMOGRAPHICS FOR ANTIDEPRESSANT DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Table 54 DEMOGRAPHICS FOR BIPOLAR DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Table 55 DEMOGRAPHICS FOR ADHD DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Table 56 DEMOGRAPHICS FOR AUTISTIC DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Table 57 DEMOGRAPHICS FOR DRUGS USED TO TREAT SCHIZOPHRENIA IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Table 58 DEMOGRAPHICS FOR LEARNING DISORDER DRUGS IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Table 59 DEMOGRAPHICS FOR EATING DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Table 60 DEMOGRAPHICS FOR CONDUCT DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Table 61 NEW DRUGS FROM ASTRAZENECA
• Table 62 NEW DRUGS FROM BRISTOL-MYERS SQUIBB
• Table 63 NEW DRUGS FROM CELGENE
• Table 64 NEW DRUGS FROM GLAXOSMITHKLINE
• Table 65 NEW DRUGS FROM JOHNSON & JOHNSON
• Table 66 NEW DRUGS FROM MERCK
• Table 67 NEW DRUGS FROM NOVARTIS
• Table 68 NEW DRUGS FROM PFIZER
• Table 69 NEW DRUGS FROM ROCHE
• Table 70 NEW DRUGS FROM SANOFI-AVENTIS
• Table 71 NEW DRUGS FROM SHIRE
• Table 72 NEW DRUGS FROM SOLVAY
• Table 73 NEW DRUGS FROM WYETH
• Table 74 ANNUAL NUMBER OF PATENTS RELATING TO TREATMENTS FOR EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2001-2005
• Table 75 TOTAL NUMBER OF PATENTS RELATING TO TREATMENTS FOR EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS BY CATEGORY, 2001-2005
• Table 76 SIGNIFICANT PATENTS FOR DRUGS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS, 2005
• Table 77 U.S. PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS BY COMPANY, 2001-2005
• Table 78 U.S. PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS BY COUNTRY, 2001-2005 (NUMBER OF PATENTS)
• Table 79 TRENDS OF PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS ISSUED BY COUNTRY, 2005-2001
• Table 80 NUMBER AND SHARE OF U.S. PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS BY ASSIGNEE, 2001-2005
• Table 81 REGIONAL SALES OF TREATMENTS FOR BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 82 REGIONAL SALES OF ANTIANXIETY AGENTS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 83 REGIONAL SALES OF ANTIDEPRESSANTS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 84 REGIONAL SALES OF BIPOLAR DISORDER DRUGS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 85 REGIONAL SALES OF ADHD DRUGS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 86 REGIONAL SALES OF AUTISTIC DISORDER DRUGS TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 87 REGIONAL SALES OF DRUGS TO TREAT SCHIZOPHRENIC DISORDERS IN CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 88 REGIONAL SALES OF LEARNING DISORDER DRUGS TO TREAT CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 89 REGIONAL SALES OF CONDUCT DISORDER DRUGS USED TO TREAT CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• Table 90 REGIONAL SALES OF EATING DISORDER DRUGS TO TREAT CHILDREN AND ADOLESCENTS, THROUGH 2010 ($ MILLIONS)
• LIST OF FIGURES
• Summary Figure:
• Figure 1 MARKET SHARES OF MANUFACTURERS OF ANTIANXIETY AGENTS TO TREAT BEHAVIOR AND EMOTIONAL DISORDERS, 2004 (%)
• Figure 2 MARKET SHARES OF MANUFACTURERS OF ANTIDEPRESSANT AGENTS TO TREAT BEHAVIOR AND EMOTIONAL DISORDERS, 2004 (%)
• Figure 3 MARKET SHARES OF MANUFACTURERS PRODUCING BIPOLAR DISORDER DRUGS, 2004 (%)
• Figure 4 MARKET SHARES OF MANUFACTURERS OF ADHD DRUGS FOR TREATING BEHAVIOR AND EMOTIONAL DISORDERS, 2004 (%)
• Figure 5 MARKET SHARES OF MANUFACTURERS OF AUTISTIC DISORDER DRUGS, 2004 (%)
• Figure 6 MARKET SHARES OF MANUFACTURERS OF DRUGS FOR TREATING SCHIZOPHRENIA, 2004 (%)
• Figure 7 MARKET SHARES OF MANUFACTURERS OF DRUGS FOR TREATING LEARNING DISORDERS, 2004 (%)
• Figure 8 MARKET SHARES OF MANUFACTURERS OF DRUGS TO TREAT EATING DISORDERS, 2004 (%)
• Figure 9 MARKET SHARES OF MANUFACTURERS OF CONDUCT DISORDER DRUGS, 2004 (%)
• Figure 10 PROPORTION OF TYPES OF DRUGS BEING USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Figure 11 WORLDWIDE SALES OF BENZODIAZEPINES USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 12 WORLDWIDE SALES OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 13 WORLDWIDE SALES OF TRICYCLIC ANTIDEPRESSANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 14 WORLDWIDE SALES OF ANTIHISTAMINES USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 15 WORLDWIDE SALES OF MAJOR TRANQILIZERS, NEUROLEPTICS OR ANTIPSYCHOTICS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 16 WORLDWIDE SALES OF MOOD STABILIZERS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 17 WORLDWIDE SALES OF CNS STIMULANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 18 WORLDWIDE SALES OF NONSTIMULANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 19 WORLDWIDE SALES OF ATYPICAL ANTIPSYCHOTICS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 20 SHARES OF GLOBAL MARKET FOR DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS BY DISORDER TYPE, 2004 (%)
• Figure 21 WORLDWIDE SALES OF ANTIANXIETY DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 22 WORLDWIDE SALES OF ANTIDEPRESSANTS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 23 WORLDWIDE SALES OF DRUGS TO TREAT BIPOLAR EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 24 WORLDWIDE SALES OF ADHD DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 25 WORLDWIDE SALES OF AUTISTIC DISORDER DRUGS USED TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 26 WORLDWIDE SALES OF SCHIZOPHRENIA DRUGS TO TREAT EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 27 WORLDWIDE SALES OF DRUGS USED TO TREAT LEARNING DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 28 WORLDWIDE SALES OF DRUGS USED TO TREAT EATING DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 29 WORLDWIDE SALES OF DRUGS TO TREAT CONDUCT DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 30 DEMOGRAPHICS OF ANTIANXIETY DRUG USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Figure 31 DEMOGRAPHICS FOR ANTIDEPRESSANT DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Figure 32 DEMOGRAPHICS FOR BIPOLAR DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Figure 33 DEMOGRAPHICS FOR ADHD DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Figure 34 DEMOGRAPHICS FOR AUTISTIC DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Figure 35 DEMOGRAPHICS FOR DRUGS USED TO TREAT SCHIZOPHRENIA IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Figure 36 DEMOGRAPHICS FOR LEARNING DISORDER DRUGS IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Figure 37 DEMOGRAPHICS FOR EATING DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Figure 38 DEMOGRAPHICS FOR CONDUCT DISORDER DRUGS USAGE IN CHILDREN AND ADOLESCENTS, 2004 (%)
• Figure 39 TOTAL PATENTS FOR EMOTIONAL AND BEHAVIORAL DISORDER TREATMENTS IN CHILDREN AND ADOLESCENTS, 2001-2005
• Figure 40 ANNUAL SHARE OF PATENTS FOR EMOTIONAL AND BEHAVIORAL DISORDER TREATMENTS IN CHILDREN AND ADOLESCENTS, 2001-2005 (%)
• Figure 41 TOTAL NUMBER OF PATENTS RELATING TO TREATMENTS FOR EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS BY CATEGORY, 2001-2005
• Figure 42 SHARE OF TOTAL NUMBER OF PATENTS RELATING TO TREATMENTS FOR EMOTIONAL AND BEHAVIORAL DISORDERS IN CHILDREN AND ADOLESCENTS BY CATEGORY, 2001-2005 (%)
• Figure 43 U.S. PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS BY COUNTRY, 2001-2005 (NUMBER OF PATENTS)
• Figure 44 TRENDS OF PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS ISSUED BY COUNTRY, 2001-2005
• Figure 45 SHARE OF PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS ISSUED BY COUNTRY, 2001-2005 (%)
• Figure 46 NUMBER OF U.S. PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS BY ASSIGNEE, 2001-2005 (NUMBER OF PATENTS)
• Figure 47 SHARES OF U.S. PATENTS RELATING TO BEHAVIORAL AND EMOTIONAL DISORDER DRUGS BY ASSIGNEE, 2001-2005 (%)
• Figure 48 REGIONAL SALES OF ANTIANXIETY AGENTS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 49 REGIONAL SALES OF ANTIDEPRESSANTS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 50 REGIONAL SALES OF BIPOLAR DISORDER DRUGS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 51 REGIONAL SALES OF ADHD DRUGS USED TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 52 REGIONAL SALES OF ADHD DRUGS TO TREAT BEHAVIORAL AND EMOTIONAL DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 53 REGIONAL SALES OF DRUGS TO TREAT SCHIZOPHRENIC DISORDERS IN CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 54 REGIONAL SALES OF LEARNING DISORDER DRUGS TO TREAT CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 55 REGIONAL SALES OF CONDUCT DISORDER DRUGS USED TO TREAT CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)
• Figure 56 REGIONAL SALES OF EATING DISORDER DRUGS TO TREAT CHILDREN AND ADOLESCENTS, 2003-2010 ($ MILLIONS)